| RS138331141 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
SCN3A-related disorder, SCN3A-related disorder |
| RS138331646 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, myofibrillar |
| RS1383321200 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1383324318 |
FKTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1X |
| RS138332774 |
UNC45A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138333004 |
BLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 11, Maturity-onset diabetes of the young type 11 |
| RS1383333220 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS138333692 |
BRAF
|
Health Risk |
Likely pathogenic |
RASopathy, Cardiovascular phenotype |
| RS138334226 |
CDAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type I |
| RS1383346134 |
ANO5
|
Health Risk |
Pathogenic/Likely pathogenic |
Miyoshi muscular dystrophy 3, Gnathodiaphyseal dysplasia |
| RS138335295 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS138335335 |
GNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-D |
| RS138335735 |
AP4B1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 47, Hereditary spastic paraplegia 47 |
| RS138336847 |
PTEN
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS1383370693 |
NGLY1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Congenital disorder of deglycosylation |
| RS138338096 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1F, Inborn genetic diseases |
| RS138339125 |
GIPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
GIPC3-related disorder, GIPC3-related disorder |
| RS138339194 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS138339540 |
MCF2L
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1383399355 |
DHTKD1
|
Health Risk |
Pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS1383401833 |
SPTA1
|
Health Risk |
Pathogenic |
— |
| RS138340807 |
DPYSL2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS138341349 |
MOCOS
|
Health Risk |
Likely pathogenic |
Xanthinuria type II, Xanthinuria type II |
| RS1383418191 |
SLC16A1
|
Health Risk |
Pathogenic |
SLC16A1-related disorder, SLC16A1-related disorder |
| RS138342076 |
MVK
|
Health Risk |
Conflicting classifications of pathogenicity |
Mevalonic aciduria, Hyperimmunoglobulin D with periodic fever |
| RS1383426312 |
CHD8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1383430588 |
SGCD
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F |
| RS138343163 |
MSTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myostatin-related muscle hypertrophy, MSTN-related disorder |
| RS138343171 |
HPS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS1383432106 |
RMRP
|
Health Risk |
Likely pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia 1 |
| RS138344683 |
ADGRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bilateral frontoparietal polymicrogyria, ADGRG1-related disorder |
| RS1383447253 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1383450519 |
HFE
|
Health Risk |
Pathogenic |
Hereditary hemochromatosis, Hereditary hemochromatosis |
| RS138345244 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease type 2 |
| RS1383452692 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS138345617 |
RINT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile liver failure syndrome 3, Infantile liver failure syndrome 3 |
| RS138346388 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome |
| RS1383465849 |
MMACHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1383481612 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1383485737 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Lung carcinoma, EGFR-related lung cancer |
| RS1383490784 |
KIAA0586
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 14 with polydactyly, Joubert syndrome 23 |
| RS1383495180 |
CTNNA1
|
Health Risk |
Likely pathogenic |
— |
| RS138350285 |
ASS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type I, Citrullinemia |
| RS138350291 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1383503951 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS138350940 |
ATR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, ATR-related disorder |
| RS138351067 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1383515185 |
SERAC1
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria with deafness, encephalopathy |
| RS1383525805 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1383530983 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS138354490 |
C2CD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Orofaciodigital syndrome type 14 |
| RS138354681 |
KIF7
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrocallosal syndrome, Nephronophthisis |
| RS1383556063 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1383559519 |
CHRND
|
Health Risk |
Pathogenic |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS138357301 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS138357499 |
DNM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 31A |
| RS138357595 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1383577532 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS138357965 |
TNNI3K
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Atrial conduction disease |
| RS138357977 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS138358075 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138358319 |
C2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138358708 |
WDR81
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebellar ataxia, intellectual disability |
| RS1383588318 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth Neuropathy X |
| RS1383589957 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS138359497 |
ABCA4
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 3, Age related macular degeneration 2 |
| RS138360045 |
RARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS138360770 |
CTSK
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyknodysostosis, Pyknodysostosis |
| RS138363524 |
SLC19A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS1383641309 |
JAM2
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS138364213 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS1383645357 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138364911 |
WDR19
|
Health Risk |
Conflicting classifications of pathogenicity |
Asphyxiating thoracic dystrophy 5, Senior-Loken syndrome 8 |
| RS138364932 |
PYGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type VI |
| RS1383649750 |
TNFRSF13B
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1383652187 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1383657728 |
PKD1
|
Health Risk |
Likely pathogenic |
Multiple renal cysts, Pancreatic cysts |
| RS1383658117 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1383664881 |
TRMT10A
|
Health Risk |
Pathogenic |
Microcephaly, short stature |
| RS138366584 |
ZNF33B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1383668573 |
MAK
|
Health Risk |
Pathogenic |
— |
| RS138367112 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS138367627 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1383679424 |
SLC52A3
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 1, Brown-Vialetto-van Laere syndrome 1 |
| RS138368397 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS1383691293 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS138370967 |
ROBO4
|
Health Risk |
Likely pathogenic |
Ascending tubular aorta aneurysm, Bicuspid aortic valve |
| RS138370992 |
TTLL5
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 19, Retinal dystrophy |
| RS138371054 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, COL6A2-related disorder |
| RS1383712865 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS138372388 |
VPS33B
|
Health Risk |
Conflicting classifications of pathogenicity |
VPS33B-related disorder, Arthrogryposis |
| RS1383726308 |
B4GALT7
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome progeroid type, Ehlers-Danlos syndrome progeroid type |
| RS138372705 |
CARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 27, Inborn genetic diseases |
| RS1383727273 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant KAT6B-related disorders, Genitopatellar syndrome |
| RS138373022 |
IFIH1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 7, Aicardi-Goutieres syndrome 7 |
| RS138373177 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Kleefstra syndrome 2 |
| RS138373307 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1383734078 |
ST3GAL5
|
Health Risk |
Pathogenic/Likely pathogenic |
GM3 synthase deficiency, GM3 synthase deficiency |
| RS138374063 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Danon disease, Cardiovascular phenotype |
| RS138374374 |
FOXP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Childhood apraxia of speech, Childhood apraxia of speech |